Dentalcare.nl Het vertrouwde hulpmiddel voor dentale professionals

Veroudering, systeemziekten en mondgezondheid: Implicaties voor vrouwen wereldwijd (Deel II)
Referenties / Bijkomende hulpmiddelen

Auteur(s) cursus: Pam Hughes, RDH, MS

Referenties

  1. Cox HG. Later life: The realities of aging, 5th ed. Upper Saddle River, NJ. Prentice-Hall 2001.
  2. WHO. Women, Ageing and Health: A Framework for Action: Focus on Gender. Accessed February 2, 2016.
  3. WHO. World health report. Global life expectancy reaches new heights but 21 million face premature death this year, warns WHO. Accessed February 2, 2016.
  4. CDC. National Center for Health Statistics. Accessed February 2, 2016. Retrieved September 2015.
  5. World Heart Federation. Women, heart disease and stroke [fact sheet]. 2011. Accessed February 2, 2016.
  6. American Heart Association (AHA). Women Heart Disease and Stroke Brochure. Updated: Dec 10, 2014. February 2, 2016.
  7. American Heart Association (AHA). Facts about Women and Cardiovascular Diseases. Accessed February 2, 2016.
  8. American Stroke Association. Women Have a Higher Risk of Stroke. Updated: Feb 5, 2014. Accessed February 2, 2016.
  9. Harvard Women's Health Watch, Preventing Stroke. Nov 2007 15(3):4-6.
  10. The Brigham and Women's Hospital Health Blog. Stroke: Five Things You Need to Know. October 23, 2014. Accessed February 2, 1016.
  11. Heart and& Stroke Foundation of Canada. Women and heart disease: The Heart Truth. August 2010. Accessed February, 2, 2016.
  12. World Health Organization. STEPwise approach to surveillance (STEPS). Accessed February 2, 2016.
  13. World Health Organization. The Stroke Surveillance Component of the WHO Global NCD InfoBase. Retrieved August 2015.
  14. Heart and Stroke Foundation of Canada. Statistics. Accessed February 2, 2016.
  15. British Heart Foundation Statistics. Accessed January 25, 2016.
  16. American Stroke Association. Types of Stroke. Accessed February 2, 2016.
  17. American Stroke Association. Understanding Risk. Accessed February 2, 2016.
  18. International Diabetes Federation. Diabetes and Cardiovascular Disease IDF. Brussels.
  19. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006 Jun;37(6):1583-633. Epub 2006 May 4.
  20. Kurth T, Everett BM, Buring JE, et al. Lipid levels and the risk of ischemic stroke in women. Neurology. 2007 Feb 20;68(8):556-62.
  21. The Heart Org. Retrieved June 2015.
  22. Lamster IB, Lalla E. Periodontal disease and diabetes mellitus: discussion, conclusions, and recommendations. Ann Periodontol. 2001 Dec;6(1):146-9.
  23. Moeintaghavi A, Haerian-Ardakani A, Talebi-Ardakani M, et al. Hyperlipidemia in patients with periodontitis. J Contemp Dent Pract. 2005 Aug 15;6(3):78-85.
  24. Kinane DF, Lowe GD. How periodontal disease may contribute to cardiovascular disease. Periodontol 2000. 2000 Jun;23:121-6.
  25. Janket SJ, Baird AE, Chuang SK, et al. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 May;95(5):559-69.
  26. Pfeifer MR, Taybos GM, Salivary Dysfunction. In Daniel & Harfst (Eds.), 2002, Mosby's Dental Hygiene: Concepts, Cases and Competencies, St. Louis, Elseiver: 664-670.
  27. Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007 Nov;120(11):936-9.
  28. Turesson C, O'Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003 Aug;62(8):722-7.
  29. Harvard Health Publications. Harvard Medical School. Harvard Women's Health June 1999 6(10):4-5. Accessed February 2, 2016.
  30. Johns Hopkins University. Pathology. Autoimmune Disorders. Accessed February 2, 2016.
  31. World Health Organization. Global burden of disease. Accessed February 2, 2016.
  32. Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006 Dec;36(3):182-8. Epub 2006 Oct 11.
  33. Padyukov L, Silva C, Stolt P, et al. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004 Oct;50(10):3085-92.
  34. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med. 2007 Sep 20;357(12):1199-209. Epub 2007 Sep 5.
  35. Vital EM, Emery P. Advances in the treatment of early rheumatoid arthritis. Am Fam Physician. 2005 Sep 15;72(6):1002, 1004.
  36. Lab Tests Online. Rheumatoid Factor. American Association for Clinical Chemistry. Accessed February 2, 2016.
  37. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315-24.
  38. Hasler P. Biological therapies directed against cells in autoimmune disease. Springer Semin Immunopathol. 2006 Jun;27(4):443-56. Epub 2006 Apr 28.
  39. Arthritis Foundation. Biologics Overview. Accessed February 2, 2016.
  40. Choi HK, Hernán MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002 Apr 6;359(9313):1173-7.
  41. National Rheumatoid Arthritis Society. Excess mortality in rheumatoid arthritis.
  42. PsychCentral. Rheumatoid Arthritis Patients Have Double the Risk of Heart Failure. Last reviewed February 21, 2009. Accessed February 2, 2016.
  43. Johns Hopkins Medicine. Arthritis Center. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. April 13, 2005. Accessed February 2, 2016.
  44. Mercado F, Marshall RI, Klestov AC, et al. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol. 2000 Apr;27(4):267-72.
  45. Mercado FB, Marshall RI, Bartold PM. Inter-relationships between rheumatoid arthritis and periodontal disease. A review. J Clin Periodontol. 2003 Sep;30(9):761-72.
  46. Pischon N, Pischon T, Kröger J, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. 2008 Jun;79(6):979-86. doi: 10.1902/jop.2008.070501.
  47. Al-Shammari KF, Al-Khabbaz AK, Al-Ansari JM, et al. Risk indicators for tooth loss due to periodontal disease. J Periodontol. 2005 Nov;76(11):1910-8.
  48. National Institute of Mental Health (NIH). Health Topics. Accessed February 2, 2016.
  49. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM). Accessed February 2, 2016.
  50. Cassano P, Fava M. Depression and public health: an overview. J Psychosom Res. 2002 Oct;53(4):849-57.
  51. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res. 2002 Oct;53(4):859-63.
  52. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res. 2002 Oct;53(4):859-63.
  53. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003 Feb;60(2):184-9.
  54. Chaudron LH, Szilagyi PG, Kitzman HJ, et al. Detection of postpartum depressive symptoms by screening at well-child visits. Pediatrics. 2004 Mar;113(3 Pt 1):551-8.
  55. Freeman MP, Wright R, Watchman M, et al. Postpartum depression assessments at well-baby visits: screening feasibility, prevalence, and risk factors. J Womens Health (Larchmt). 2005 Dec;14(10):929-35.
  56. WebMD. Burt VK. Women with Depression Have Special Needs, Considerations. Accessed February 2, 2016.
  57. Ross LE, Steiner M. A biopsychosocial approach to premenstrual dysphoric disorder. Psychiatr Clin North Am. 2003 Sep;26(3):529-46.
  58. Dreher JC, Schmidt PJ, Kohn P, et al. Menstrual cycle phase modulates reward-related neural function in women. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2465-70. Epub 2007 Jan 31.
  59. Munk-Olsen T, Laursen TM, Pedersen CB, et al. New parents and mental disorders: a population-based register study. JAMA. 2006 Dec 6;296(21):2582-9.
  60. Bebbington PE, Dunn G, Jenkins R, et al. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity . Psychol Med. 1998 Jan;28(1):9-19. Erratum in: Psychol Med 1998 Sep;28(5):1253.
  61. Freeman EW, Sammel MD, Lin H, et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006 Apr;63(4):375-82.
  62. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006 Feb 1;295(5):499-507. Erratum in: JAMA. 2006 Jul 12;296(2):170.
  63. Rohan KJ, Lindsey KT, Roecklein KA, et al. Cognitive-behavioral therapy, light therapy, and their combination in treating seasonal affective disorder. J Affect Disord. 2004 Jun;80(2-3):273-83.
  64. Reynolds CF 3rd, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med. 2006 Mar 16;354(11):1130-8.
  65. Center for Disease Control and Prevention. (CDC). Accessed February 2, 2016.
  66. National Institute for Health and Clinical Excellence. (NICE). Accessed February 2, 2016.
  67. Olié JP, Elomari F, Spadone C, et al. [Antidepressants consumption in the global population in France] Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7.
  68. Raymond CB, Morgan SG, Caetano PA. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatr Serv. 2007 Jan;58(1):79-84.
  69. Meijer WE, Heerdink ER, Leufkens HG, et al. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol. 2004 Mar;60(1):57-61. Epub 2004 Feb 19.
  70. McManus P, Mant A, Mitchell PB, et al. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med J Aust. 2000 Nov 6;173(9):458-61.56
  71. Top 200 Generic Drugs by Units in 2006. Drug Topics. Mar 2007;151(5):25.
  72. U.S. Food and Drug Administration. Guidance for Industry. Warnings and Precautions, Contraindications, and Boxed Warning Sections of Labeling for Human Prescription Drug and Biological Products – Content and Format. October 2011. Accessed February 2, 2016.
  73. Heanue M, Deacon SA, Deery C, et al. Manual versus powered toothbrushing for oral health. Cochrane Database Syst Rev. 2003;(1):CD002281.
  74. Robinson PG, Deacon SA, Deery C, et al. Manual versus powered toothbrushing for oral health. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002281.
  75. Deacon SA, Glenny AM, Deery C, et al. Different powered toothbrushes for plaque control and gingival health. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD004971. doi: 10.1002/14651858.CD004971.pub2.
  76. Schiff T, Saletta L, Baker RA, et al. Desensitizing effect of a stabilized stannous fluoride/Sodium hexametaphosphate dentifrice. Compend Contin Educ Dent. 2005 Sep;26(9 Suppl 1):35-40.
  77. Schiff T, He T, Sagel L, et al. Efficacy and safety of a novel stabilized stannous fluoride and sodium hexametaphosphate dentifrice for dentinal hypersensitivity. J Contemp Dent Pract. 2006 May 1;7(2):1-8.
  78. Mankodi S, Bartizek RD, Winston JL, et al. Anti-gingivitis efficacy of a stabilized 0.454% stannous fluoride/sodium hexametaphosphate dentifrice. J Clin Periodontol. 2005 Jan;32(1):75-80.
  79. Perlich MA, Bacca LA, Bollmer BW, et al. The clinical effect of a stabilized stannous fluoride dentifrice on plaque formation, gingivitis and gingival bleeding: a six-month study. J Clin Dent. 1995;6 Spec No:54-8.
  80. Beiswanger BB, Doyle PM, Jackson RD, et al. The clinical effect of dentifrices containing stabilized stannous fluoride on plaque formation and gingivitis--a six-month study with ad libitum brushing. J Clin Dent. 1995;6 Spec No:46-53.
  81. Gerlach RW, Garcia-Godoy C, Walanski A, et al. Research Summary: A Clinical Trial to Assess the Effect of a Regimen including a Novel Stannous Fluoride Dentifrice, Power Toothbrush and Floss on Gingivitis [881]. Accessed February 2, 2016.
  82. Mankodi S, Bauroth K, Witt JJ, et al. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque. Am J Dent. 2005 Jul;18 Spec No:9A-14A.
  83. Charles CH, Mostler KM, Bartels LL, et al. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol. 2004 Oct;31(10):878-84.
  84. The Oral Cancer Foundation. Xerostomia. Accessed February 2, 2016.

Bijkomende hulpmiddelen

Hartziekten en beroertes


Reumatoïde artritis


Depressie

  • National Alliance for the Mentally Ill
  • Toll-free, 24-hour hotline of the National Suicide Prevention
  • Lifeline at 1-800-273-8255; 1-800-799-4889 for a trained counselor at a suicide crisis center.
  • Food and Drug Administration
Afdrukken